Literature DB >> 10023073

The human genome has only one functional hsp47 gene (CBP2) and a pseudogene (pshsp47).

N Nagai1, Y Tetuya, N Hosokawa, K Nagata.   

Abstract

Among all the species investigated to date, only in humans is hsp47 reported to exist as two separate genes. Here we examined whether hsp47 forms a gene family, and if so, how many genes constitute the family. Cloning and sequencing of human hsp47 cDNA revealed that only one gene, identical to CBP2, was transcribed. No transcript corresponding to colligin, which was reported to be a human homologue of hsp47, was found. Genomic southern hybridization using the exon III fragment of mouse hsp47 as a probe, however, showed two bands for several restriction enzyme digests. We cloned and sequenced the gene corresponding to the extra band and found that a pseudogene (pshsp47) existed in the human genome. We have mapped this pseudogene to chromosome 9p12-p13 by fluorescent in situ hybridization (FISH) using a 3.5kb genomic fragment containing the entire pshsp47 sequence as a probe. These results suggested that functional hsp47 exists as CBP2, not as colligin, and a highly conserved pseudogene is present in the human genome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023073     DOI: 10.1016/s0378-1119(98)00592-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Guidelines for the nomenclature of the human heat shock proteins.

Authors:  Harm H Kampinga; Jurre Hageman; Michel J Vos; Hiroshi Kubota; Robert M Tanguay; Elspeth A Bruford; Michael E Cheetham; Bin Chen; Lawrence E Hightower
Journal:  Cell Stress Chaperones       Date:  2008-07-29       Impact factor: 3.667

2.  Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.

Authors:  Noriko Yamamoto; Takashi Kinoshita; Nijiro Nohata; Hirofumi Yoshino; Toshihiko Itesako; Lisa Fujimura; Akira Mitsuhashi; Hirokazu Usui; Hideki Enokida; Masayuki Nakagawa; Makio Shozu; Naohiko Seki
Journal:  Int J Oncol       Date:  2013-10-18       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.